Sirolimus Interactions

Sirolimus Interactions is a pharmacological construct that denotes the modulatory effects of sirolimus on the pharmacokinetics and pharmacodynamics of co-administered agents in transplant recipients, distinguished by its mechanistic basis in mTOR inhibition and P-glycoprotein-mediated drug disposition.

69

Publications

3.1K

Citations

337

Authors

121

Institutions

Publications per year

2017–2026

3

Authors

337

  1. SM
    Stanislaw M. Stepkowski

    The University of Texas at Austin, United States

    8 publications · 650 citations

    8

    h-index

  2. BD
    Barry D. Kahan

    The University of Texas at Austin, United States

    7 publications · 564 citations

    7

    h-index

  3. KL
    Kimberly L. Napoli

    The University of Texas at Austin, United States

    5 publications · 481 citations

    5

    h-index

  4. TC
    Ting‐Chao Chou

    Memorial Sloan Kettering Cancer Center, United States

    5 publications · 490 citations

    5

    h-index

  5. WJ
    William J. Jusko

    University at Buffalo, State University of New York, United States

    3 publications · 142 citations

    3

    h-index

1–5 of 337

Venues

  1. Transplantation

    9 publications · 441 citations

    9

    h-index

  2. Transplantation Proceedings

    6 publications · 209 citations

    6

    h-index

  3. Therapeutic Drug Monitoring

    4 publications · 148 citations

    4

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 3 publications · 121 citations

    3

    h-index

  5. PubMed

    Repository · 3 publications · 124 citations

    3

    h-index

1–5